Skip to main content
. 2009 Mar 9;53(5):2120–2128. doi: 10.1128/AAC.01012-08

TABLE 2.

Effect of combinations of amantadine, oseltamivir carboxylate, and ribavirin on an influenza A/Duck/MN/1525/81 (H5N1) amantadine-resistant virus infection in MDCK cells

Drug Concn (μM) Virus titers with:a
Amantadine (μM)
Ribavirin (μM)
100 32 10 3.2 1 0 100 32 10 3.2 1.0 0
Oseltamivir carboxylate 10 0 ± 0 0.7 ± 1.2 0.6 ± 1.0 0.7 ± 1.2 0.6 ± 1.0 0.7 ± 1.2 0 ± 0 0 ± 0 0.6 ± 1.0 0.5 ± 0.9 0.4 ± 0.8 0.7 ± 1.2
3.2 1.6 ± 1.5 1.8 ± 0.7 1.5 ± 1.4 1.8 ± 1.7 1.4 ± 1.4 1.6 ± 1.5 0 ± 0 0 ± 0 1.3 ± 1.2 1.7 ± 1.5 1.7 ± 1.5 1.5 ± 1.5
1.0 4.1 ± 0.5 4.5 ± 0.5 4.3 ± 0.8 4.6 ± 0.7 3.9 ± 0.8 4.2 ± 0.5 0 ± 0 0.2 ± 0.4 3.7 ± 0.3 4.3 ± 0.0 4.4 ± 0.1 4.6 ± 0.5
0.32 5.2 ± 0.8 5.4 ± 0.2 5.3 ± 0.4 5.4 ± 0.6 5.2 ± 0.6 4.7 ± 0.9 0 ± 0 1.2 ± 1.0 4.6 ± 0.9 4.9 ± 0.9 5.2 ± 0.8 5.1 ± 0.5
0.1 5.3 ± 0.8 5.5 ± 0.0 5.7 ± 0.4 5.7 ± 0.3 5.6 ± 0.1 5.0 ± 0.9 0 ± 0 2.1 ± 1.9 4.9 ± 0.7 5.0 ± 0.9 5.4 ± 0.6 5.5 ± 0.3
0 5.6 ± 0.3 5.8 ± 0.2 5.7 ± 0.3 5.6 ± 0.4 5.6 ± 0.4 5.5 ± 0.5 0 ± 0 2.5 ± 2.2 5.4 ± 0.5 5.2 ± 0.5 5.5 ± 0.2 5.6 ± 0.4
Amantadine 100 0 ± 0 1.6 ± 1.7 4.5 ± 0.5 5.1 ± 0.5 5.5 ± 0.9 5.5 ± 0.2
32 0 ± 0 2.0 ± 1.8 4.9 ± 0.3 5.5 ± 0.2 5.5 ± 0.2 5.9 ± 0.1
10 0 ± 0 2.3 ± 2.0 4.9 ± 0.4 5.5 ± 0.4 5.5 ± 0.2 5.8 ± 0.1
3.2 0 ± 0 2.1 ± 1.9 4.7 ± 0.0 5.3 ± 0.5 5.3 ± 0.5 5.6 ± 0.4
1 0 ± 0 2.1 ± 1.9 4.7 ± 0.3 5.2 ± 0.5 5.4 ± 0.2 5.6 ± 0.4
0 0 ± 0 2.6 ± 2.3 4.8 ± 0.3 5.4 ± 0.1 5.5 ± 0.1 5.6 ± 0.1
a

The values are means ± standard deviations (n = 3 independent assays) of virus titers (log10 CCID50/0.1 ml). The volume of synergy value, as calculated by the method of Prichard and Shipman (23), was 1.81 for oseltamivir carboxylate and amantadine, 3.95 for oseltamivir carboxylate and ribavirin, and 5.74 for amantadine and ribavirin. Boldface values indicate regions of synergy.